We describe two novel technique for contrast enhancement in optical coherence tomography (OCT) which enables molecular specific imaging. The first, a pump-probe technique, is employed in which a pulsed pump laser is tuned to ground-state absorption in a molecule of interest. The location of the target molecule population is derived from the resulting transient absorption of OCT sample arm light acting as probe light. Preliminary results exhibiting contrast enhancement in cross-sectional OCT images using methylene blue dye are presented. The second method is an optical switch suppression technique based on the use of a transmembrane protein called bacteriorhodopsin. Initial experiments indicate that biochemical optical switches, such as bacteriorhodopsin, are excellent contrast agent candidates for molecular contrast OCT.
external pump beam. The second is based on an optical switch suppression technique. The molecular contrast agents are biochemical optical switches, such as bacteriorhodopsin. These methods are centered on the exploitation of various optical properties in selected contrast agents to elicit changes in the OCT images acquired. These images can then be processed to reveal the concentration distribution of the contrast agents in the target.
The addition of molecular-specific contrast capability to OCT imaging would enable a large number of applications which are not presently possible with OCT. The potential applications for molecular contrast OCT technology include quantitative biological microscopy and noninvasive medical diagnostics. Laboratory OCT microscopy systems adapted for molecular contrast would enable quantitative imaging of exogenous probes and markers in cellular preparations and animal models, with improved imaging depth compared with fluorescence, confocal, or multi-photon microscopy. Contrast agents of interest for molecular contrast OCT include genetically expressible probes under the control of specialized promoters. Clinical OCT systems adapted for molecular contrast may enable diagnostic imaging of endogenous tissue chromophores relevant to disease processes, as well as in situ monitoring of therapeutic processes such as drug delivery.
Pump-probe technique based molecular contrast OCT (PPOCT)
Pump-probe spectroscopy is a standard tool in nonlinear optics for characterization of light induced changes in optical properties of materials, and for studying the relaxation dynamics of excited states [2] . We chose methylene blue as a demonstration contrast agent for PPOCT because it has spectrally distinct ground-state absorption in the visible region and triplet-triplet absorption in the 830 nm region, which is commonly used for OCT [3] .
Generally speaking, pump probe OCT [4] relies on the use of a pump beam to transiently change the absorption of the target contrast agent at a probe wavelength which is used as the wavelength of an OCT imaging system. The difference in the OCT signal acquired at the probe wavelength as a function of the pump intensity can then be used to profile the contrast agent concentration distribution in the target sample. The transient nature of the target absorption can be used to implement time-gated or frequency-domain signal processing schemes which maximize the signal-to-noise ratio in the associated measurement. Such a scheme requires the use of contrast agents that have the requisite excitation energy level scheme that will permit a pump beam induced change of absorption coefficient at the probe wavelength. It is to be understood that the change in absorption may be of either sign, which is to say that the pump beam may either increase or decrease the absorption of the sample at the probe wavelength. It is also to be understood that the absorption itself may be of either sign; positive absorption corresponds to absorption in the conventional sense, and negative absorption corresponds to stimulated emission, which is a coherent process and is thus compatible with interferometric detection.
The experimental apparatus we used for PPOCT is illustrated in Fig. 2 . A femtosecond Ti:sapphire laser output (center wavelength 800 nm, spectral bandwidth 90 nm), was used as the light source for OCT and a rapid scanning optical delay (RSOD) operating at 2kHz line rate was used for high speed acquisition of OCT A-scans. The source light was pulse-stretched with ~30 m singlemode fiber to ensure that nonlinear excitation of the dye sample by the OCT probe light did not occur. The sample was pumped through a dichroic mirror by second harmonic light from a Q-switched Nd-Yag laser (532 nm, ~50 ns pulse width, 10-50 µJ/pulse, 1 kHz repetition rate, focal spot ~40 µm). A holographic notch filter (HNF) prevented pump light from entering the OCT receiver. A computer-controlled delay generator triggered by the RSOD line sync triggered both the pump laser Q-switch and the synchronized detection electronics. Balanced detection was used to suppress non-interferometric transient absorption of sample arm light. Demonstration of depthresolved molecular contrast imaging using pump-probe OCT in a nonscattering phantom is illustrated in Fig. 3 (a) and (b). The sample was a 2-level well phantom, consisting of three microscope cover slips spaced ~500 µm apart with pure water and ~0.5 mM methylene blue dye in water alternatively placed in wells between the slips. OCT and PPOCT data were acquired with the dye in alternate compartments. Averaged OCT and PPOCT A-scans are displayed in columns (a) and (b), respectively. The depth-resolved PPOCT A-scans clearly show the presence of differential signal at the bottom of the dye layer and at all sequential interfaces, reflecting the cumulative nature of the PPOCT signal. Larger signals (both OCT and PPOCT) are observed at external (glass-air) as compared to internal (glass-water) interfaces. Small artifacts in the PPOCT scans are observed at the level of the top glass-air interface, possibly due to nonlinear receiver response at this large reflection. Preliminary demonstrations of molecular contrast PPOCT imaging in a scattering medium were obtained using ~0.5 mM of methylene blue dye mixed into intravenous fat emulsion (Liposyn®, ~0.5% solids). Figure 3 (c) illustrates log OCT and log PPOCT M-scans acquired within a single-layer cover slip phantom of ~.5 mm thickness, as the pump laser was alternately blocked and unblocked. A separate experiment (not shown) verified that no PPOCT signal was observed under identical experimental conditions, in the absence of dye in the scattering medium. Fig. 3 (d) illustrates log OCT and log PPOCT images of a glass capillary tube (outer diameter ~1.6 mm) containing ~0.5 mM of methylene blue dye in Liposyn, partially submerged in 0.5% lyposin without dye. The PPOCT image shows the signal only within the tube containing the dye. The central defect in the PPOCT image is attributed to saturation of the receiver from the strong reflection at the tube apex.
In summary, we have introduced a novel implementation of molecular contrast OCT that is capable of imaging molecular contrast distribution within a sample. Although the pump power levels and data acquisition times used in this preliminary study are not suitable for biological or medical applications, much more efficient implementations of PPOCT which optimize the temporal overlap of the pump and probe inputs are under development in our laboratory. The spectral selectivity of the technique offers flexibility to choose different contrast agents depending on the excitation source and transient spectra. The spatial and spectral selectivity of the nonlinear optical approach in PPOCT may have potential for enhancing OCT with the power of molecular-specific spectroscopic contrast for functional imaging.
Biochemical optical 'switch' suppression molecular contrast OCT technique
We have began experimentation with a new class of contrast agentsbiochemical species that can be reversibly switched from one stable state to another through a specific wavelength excitation. This state change also causes an associated change in the absorption spectrum.
One notable example of such biochemical optical switch is bacteriorhodopsin (bR) [5] . This is a retinol based transmembrane protein that has evolved in swamp bacteria as part of the engine for converting sunlight into energy.
The advantages of using bR are numerous. Bacteriorhodopsin switches between two major state groups upon excitation. In its original D&B state group, bacteriorhodopsin absorbs the red-green portion of the spectrum strongly. Upon exposure to light of wavelength 500-800 nm, it transits into its M state. In this state, bR absorbs strongly in the UV region of the spectrum. An experimental transmission spectrum measurement scan of these 2 state groups of bR is shown in Fig. 4 (note that the transition was incomplete and the spectrum change less dramatic, due to the lack of available high light source intensity in the spectrophotometer). bR in M state will transit back to D&B state group upon excitation with UV light or after tens of milliseconds. The excitation intensity required for either state change is dramatically low -measured to be ~ 75 mW/cm 2 (equivalent to the intensity of a typical laser pointer), which makes state change in bR very easy to achieved. Fig. 5 shows that the optical density change in bR plateau at the intensity reported above.
With a probe wavelength of 630 nm, we will actually cause bR within the sample to immediately make a transition to its M state at our typical OCT probe intensity. In order to attain OCT scans of bR distribution in its D&B state, we use a state change suppression UV beam at 408nm. The experiment scheme for extracting molecular contrast information is illustrated in the cartoon in Fig. 6 . This scheme has yielded great experimental feasibility promise. Figure 7 shows an A-scan through a 1 mm cuvette of bR acquired with the 100µW probe of 630nm and a suppression 3 mW UV beam of 408nm.
